ArticleVaccines2022

SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine.

Béatrice Clémenceau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.